These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20607912)

  • 1. Treatment. HIV drug spending up; Merck offers discounts.
    AIDS Policy Law; 2010 Jun; 25(7):1. PubMed ID: 20607912
    [No Abstract]   [Full Text] [Related]  

  • 2. The looming crisis in drug pricing.
    Delaney M
    GMHC Treat Issues; 2002 Apr; 16(4):12. PubMed ID: 12141258
    [No Abstract]   [Full Text] [Related]  

  • 3. Glaxo drops drug prices, AIDS foundation drops suit.
    AIDS Policy Law; 2003 May; 18(10):6. PubMed ID: 12809097
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug pricing.
    AIDS Treat News; 2001 Jan; (377):6. PubMed ID: 11862811
    [No Abstract]   [Full Text] [Related]  

  • 5. Glaxo Wellcome expands Patient Assistance Program for 3TC.
    AIDS Patient Care STDS; 1996 Aug; 10(4):262. PubMed ID: 11361605
    [No Abstract]   [Full Text] [Related]  

  • 6. Policy watch. Profitable pills.
    Gebbie KM
    AIDS Read; 2004 Mar; 14(3):106, 109. PubMed ID: 15067998
    [No Abstract]   [Full Text] [Related]  

  • 7. Uganda cuts AIDS drug deal.
    IAPAC Mon; 2001 Feb; 7(2):40. PubMed ID: 11302022
    [No Abstract]   [Full Text] [Related]  

  • 8. Merck, Bristol-Myers Squibb announce major price reductions for poorest countries: major access progress but questions remain.
    James JS
    AIDS Treat News; 2001 Feb; (361):5-7. PubMed ID: 12765151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Glaxo Wellcome, Germany, spends 60.000 DM for African HIV projects in Uganda and Malawi].
    Krankenpfl J; 1999 Dec; 37(12):479. PubMed ID: 10734858
    [No Abstract]   [Full Text] [Related]  

  • 10. Senegal cuts deal for low-cost drugs.
    IAPAC Mon; 2001 Jan; 7(1):4. PubMed ID: 11305274
    [No Abstract]   [Full Text] [Related]  

  • 11. Africa finds drug giants guilty of excessive pricing.
    AIDS Policy Law; 2003 Dec; 18(22):5. PubMed ID: 14974397
    [No Abstract]   [Full Text] [Related]  

  • 12. Trip into the unknown.
    Anderson T
    Nature; 2007 Nov; 450(7169):471. PubMed ID: 18033269
    [No Abstract]   [Full Text] [Related]  

  • 13. The public-sector safety net for HIV-related care.
    Buchanan RJ
    AIDS Public Policy J; 1999; 14(3):97-104. PubMed ID: 10935046
    [No Abstract]   [Full Text] [Related]  

  • 14. ADAP funding crisis: talking points.
    AIDS Treat News; 2001 Sep; (371):4-5. PubMed ID: 11668977
    [No Abstract]   [Full Text] [Related]  

  • 15. [HIV therapy: tenofir DF is available in 68 developing countries at production costs price].
    Med Klin (Munich); 2003 Jul; 98(7):XV-XVI. PubMed ID: 12945544
    [No Abstract]   [Full Text] [Related]  

  • 16. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug firms drop drug case against South Africa.
    AIDS Policy Law; 2001 May; 16(9):3. PubMed ID: 11668825
    [No Abstract]   [Full Text] [Related]  

  • 18. Some thoughts on troubled ADAPs and Medicaid.
    Pietrandoni G
    Posit Aware; 2003; 14(4):42. PubMed ID: 12951952
    [No Abstract]   [Full Text] [Related]  

  • 19. AIDS activists decry steady hikes in HIV drug prices.
    AIDS Policy Law; 2005 Jul; 20(14):1, 4. PubMed ID: 16110523
    [No Abstract]   [Full Text] [Related]  

  • 20. Companies reduce prices for HIV drugs in developing countries.
    Gottlieb S
    Bull World Health Organ; 2000; 78(6):862. PubMed ID: 10916926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.